02 June 2022 Calym
Rise of the Artificial Intelligence program o...
The Artificial Intelligence program of the Carnot Institute CALYM has been ...
23 May 2022 Lysa
LYSA studies presented during 2022 ASCO and E...
2 oral communications an 4 posters presented by LYSA in the program of thes...
19 May 2022 Calym
RedTalks S2#6: Application of PET scanning in...
We are very pleased to introduce Pr. Judith Trotman, a lymphoma clinician r...
16 May 2022 Lysa
Health’s Broadcast Magazine de la santé &#...
The reference health broadcast called Le Magazine de la santé on France 5,...
24 March 2022 Calym
CALYM members at the SFH
14 March 2022 Calym
RedTalks Season2#5: CAR-T cells: new targets ...
01 March 2022 Lysarc
ARCs/TECs day at the SFH congress
10 February 2022 Lysarc
Launch of the VERLEN study
VERLEN est une étude qui vise à évaluer l'efficacité d'une nouvelle com...
07 February 2022 Calym
RedTalks Season2#4: Could polatuzumab dethron...
05 January 2022 Calym
RedTalks Season2#3: Circulating tumor DNA (ct...
29 December 2021 Calym
CALYM: strong dynamics engaged with FINDMED
13 December 2021 Lysarc
The 3000th patient included in REALYSA –...
10 December 2021 Lysarc
ASH 2021: LYSA and LYSARC to present their si...
08 December 2021 Calym
AMERICAN SOCIETY OF HEMATOLOGY ANNUAL MEETING...
01 December 2021 Calym
A STRUCTURING INTEGRATING THE ENTIRE VALUE CH...
29 November 2021 Calym
Congratulations to the 2 new winners of the C...
24 November 2021 Calym
ANTICANCER CELL THERAPY GROUP AND INSTITUT CA...
21 November 2021 Lysa
LYSARC – Review of the 2020 Assessment ...
LYSARC - 2020 Review and outlook for 2021
14 November 2021 Lysarc
The 2020 academic clinical research activity ...
04 November 2021 Lysa
American Society of Hematology annual meeting...
03 November 2021 Lysarc
1000 patients included in the DESCAR-T regist...
02 November 2021 Calym
ISSUES IN LYMPHOMA RESEARCH
22 October 2021 Calym
14th edition of the Rendez-vous Carnot
20 October 2021 Calym
RedTalks Season2 #2: PDX a powerful tool of n...